Log in
Enquire now
‌

QUANTUM SIMULATION TECHNOLOGIES INC SBIR Phase I Award, September 2023

A SBIR Phase I contract was awarded to QSimulate in September, 2023 for $273,361.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributorsActivity

Contents

AbstractTimelineTable: Further ResourcesReferences
sbir.gov/node/2512009
Is a
SBIR/STTR Awards
SBIR/STTR Awards
1

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
QSimulate
QSimulate
1
Government Agency
Loading...
1
Government Branch
National Institutes of Health
National Institutes of Health
1
Award Type
SBIR1
Contract Number (US Government)
1R43GM151906-011
Award Phase
Phase I1
Award Amount (USD)
273,3611
Date Awarded
September 1, 2023
1
End Date
August 31, 2024
1
Abstract

Project Summary Computational chemistry has revolutionized drug discovery, reducing by months or even years the amount of time it takes to discover and refine a lead candidate. Nowhere has the contribution of computational chemistry been greater than in the realm of virtual screening (VS) to identify an initial hit to a drug target receptor. It is now routine to screen 106-108 virtual compounds via molecular docking to identify potential binders. A small number of these will be purchased and screened, which is a slower and more expensive process. While docking is demonstrably useful for brute force triage, it is also generally unreliable for rank-ordering the compounds that survive the triage. There is a substantial and unmet need for computational methods that are better at rank ordering that can further reduce the number of compounds that survive to purchase/screening. Interest is growing in an approach termed ABFE, in which the Absolute Binding Free Energies of diverse ligands can be evaluated for a common protein receptor target. This approach is a natural outgrowth of relative binding free energy (RBFE) methods, the most well-known of which is Free Energy Perturbation (FEP). In recent years, the application of FEP for hit-to-lead optimization has exploded, thanks to increasing computer resources and automized workflows. With a reliable ABFE approach, further enrichment of the potential binders that come from dock-based screening can be obtained, improving the cost/hit ratio for the expensive experimental tail of the screening campaign. Based on FEP, the computational formalism that would make ABFE calculations possible within the screening paradigm has been described, and a few publications have demonstrated that it is, indeed, capable of further enriching the compounds that survive the molecular docking screen. These calculations have still been limited by two issues: 1) Computational throughput; 2) Limitations of the Molecular Mechanics (MM) force field that has been exclusively used in these ABFE/FEP simulations. The limitations of computational throughput are increasingly addressed by expansion in the availability of cloud resources, so the limitations of the MM force field are the primary issue. We propose an ABFE/FEP approach that replaces the limited MM representation with one based on a combined quantum mechanics (QM) +MM approach: QM/MM—where the region of ligand binding is treated using QM. In contrast to MM, QM describes molecular energetics much more exactly, and is broadly appliable to all classes of molecular ligands, unlike MM, which has a large number of known limitations/deficiencies. We will apply ABFE/FEP calculations to a variety of systems to validate the approach within the context of virtual screening, and to demonstrate the improvements that QM/MM allows versus traditional MM approaches.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like QUANTUM SIMULATION TECHNOLOGIES INC SBIR Phase I Award, September 2023

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.